Anti-C1q Antibody, IgG
Also known as: ANTI-C1Q
Use
The presence of the anti-C1q IgG antibody is associated with an increased risk of lupus nephritis or systemic lupus erythematosus (SLE) global activity. These antibodies are not specific for SLE, so a strong clinical correlation with the disease is recommended.
Special Instructions
Specimen should be separated from cells as soon as possible or within 2 hours of collection for optimal results.
Limitations
Anti-C1q antibodies are not specific for SLE and should be interpreted in conjunction with other clinical information. False positives may occur, and the presence of these antibodies alone cannot confirm a diagnosis.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 44702-9
Result Turnaround Time
1-15 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.15 mL
Container
ARUP standard transport tube
Collection Instructions
Separate serum from cells ASAP or within 2 hours of collection.
Causes for Rejection
Urine or plasma. Contaminated, heat-inactivated, severely hemolyzed or severely lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |